Kevin N. Heller

Insider Reports History

Location
Beltsville, MD
Signature
/s/ Jeet Mahal, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin N. Heller:

Company Role Class Num Shares Value Price $ Report Date Ownership
Jasper Therapeutics, Inc. Executive Vice President, Research and Development Stock Option (right to buy) 7,500 21 Mar 2022 Direct

Insider Reports Filed by Kevin N. Heller

Symbol Company Period Transactions Value $ Form Type Role Filing Time
JSPR Jasper Therapeutics, Inc. 21 Mar 2022 1 $0 4 Executive Vice President, Research and Development 23 Mar 2022, 18:04
JSPR Jasper Therapeutics, Inc. 24 Sep 2021 0 $0 3 EVP, Research and Development 01 Oct 2021, 16:10